Medtech Insight and Windhover Information Announce the 'In3 Medical Device Summit' Early-Stage Medical Technology Investment and Partnering Conference, June 21-23, 2006, San Francisco.

NEWPORT BEACH, Calif. -- Program to Feature Partnering Software and Three Tracks of Presentations by 60+ Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership

Medtech Insight has announced that it is hosting its largest medical technology strategic investment and partnering event for medical technology executives, the "Investment In Innovation (In3) Medical Device Summit," June 21-23, 2006, at The Palace Hotel in San Francisco. The In3 Summit is the most important venue of its kind for previewing cutting-edge emerging medical technology companies and engaging with the biggest dealmakers in the industry, including senior executives from the device industry and healthcare investment community. All attendees will benefit from the mix of quality presentations, speakers, roundtables, workshops and panels addressing the hottest topics in the ever-more competitive and lucrative medical technology marketplace, along with the unmatched networking and partnering opportunities that attendees have come to expect from Investment In Innovation (In3) events over the past five years.

Conference highlights will include presentations by more than 60 emerging medical technology companies, focused into three tracks, each followed by break-out sessions in private conference rooms. One track will consist of Cardiovascular and Peripheral Vascular Diagnostics and Therapeutics companies, the second track will feature Orthopedics and Spine companies, and the third track will highlight other high-growth technologies such as Drug Delivery, Gastrointestinal, General Surgery, Imaging, Metabolic Disorders, Neurology, Oncology, Ophthalmology, Tissue Engineering, and Uro/Gynecology, among others.

At the In3 Summit, attendees will benefit from networking with hundreds of potential partners and benchmarking dealmaking strategies against peers and competitors; partnering opportunities, lessons learned and practical advice from the venture capital community; keynote presentations by prominent device industry executives; case studies and lessons learned from senior level, mid-size, large company and VC roundtable and feature presentations; focused physician/end-user panels; and focused start-up company educational workshops. Unique partnering software allows attendees to search company and delegate profiles, as well as a database of licensing opportunities provided by the attendees themselves, and also communicate and directly schedule meetings with prospective partners. Visit the In3 Summit Web site at www.meddevicesummit.com for the preliminary agenda and other regularly updated event details.

Confirmed panelists for the Friday morning, June 23 Investing in Medical Technology Panel Discussion titled "What are the Hot Deals Now and in the Future" include Tom Fogarty, Partner, Three Arch Partners; Trevor Moody, Partner, Frazier Healthcare Ventures; Rich Ferrari, Managing Director, De Novo Ventures; Leslie Bottorff, General Partner, Medical Technology Onset Ventures; Sami Hamade, Vice President, Compass Group, Guidant Corp.; and David L. Douglass, General Partner, Delphi Ventures. Topics to be covered by this panel include how to capitalize on the medtech industry; why invest in certain technologies and companies; the rationale behind investments; and picks for deals of the year and why.

In3 Summit co-sponsors include AdvaMed, Battelle, Business Wire, Finnegan Henderson Farabow Garrett & Dunner LLP, Harvard Clinical Research Institute (HCRI), Medmarc and The Hartford, Reimbursement Principles, Ronald Trahan Associates, Teledyne Medical Microsystems, The MedTech Group, and Underwriters Laboratories.

To register to attend or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail [e-mail]. Through March 31, 2006, attendees registering for the conference can save $300 off the $1,495 registration fee.

Medtech Insight's medical technology investment and partnering conferences have drawn over 5,850 attendees and more than 650 innovative early-stage presenting companies since their inception, making them the premier investment, partnering and networking event in the medical technology industry.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.